John J. Chen, MD, PhD, of Mayo Clinic discusses how NMOSD and MOGAD antibodies are changing optic neuritis care and the two trials now enrolling.
John J. Chen, MD, PhD
Advertisement
John J. Chen, MD, PhD, is a neuro-ophthalmologist at Mayo Clinic in Rochester, Minnesota.
Articles by John J. Chen, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: BRUNELLO 1-year results for remigromig in DME
2
AAO 2026: Optogenetic gene therapy heads to phase 2 trial in geographic atrophy
3
AAO 2026: DAYBREAK shows tarcocimab and tabirafusp-ted noninferior to aflibercept in wet AMD
4
Real-world VOYAGER data on faricimab in nAMD, DME, RVO at EURETINA 2026
5